Article thumbnail

Integrin αvβ5 is a primary receptor for adenovirus in CAR-negative cells

By Cynthia Lyle and Frank McCormick
Topics: Research
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2005). A: Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity.
  2. (2008). Adenovirus serotype 5 hexon mediates liver gene transfer. Cell
  3. (2009). Adenovirus serotype 5 infects human dendritic cells via a coxsackievirus-adenovirus receptor-independent receptor pathway mediated by lactoferrin and DC-SIGN.
  4. (2009). Adenoviruses: update on structure and function.
  5. (2007). AH: Influence of coagulation factor zymogens on the infectivity of adenoviruses pseudotyped with fibers from subgroup D. J Virol
  6. (2007). AH: Targeting of adenovirus serotype 5 (Ad5) and 5/47 pseudotyped vectors in vivo: fundamental involvement of coagulation factors and redundancy of CAR binding by Ad5. J Virol
  7. (2008). An alteration of human immunodeficiency virus gp41 leads to reduced CCR5 dependence and CD4 independence.
  8. (2004). Arias CF: Multistep entry of rotavirus into cells: a Versaillesque dance. Trends Microbiol
  9. (2007). Arnberg N: Adenoviruses use lactoferrin as a bridge for CAR-independent binding to and infection of epithelial cells.
  10. (2005). Bergelson JM: Adenovirus receptors.
  11. (1993). Binding to sialic acids is not an essential step for the entry of animal rotaviruses to epithelial cells in culture.
  12. (2005). BL: What does it take to bind CAR? Mol Ther
  13. (2000). Cabrini G: Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions. Virology
  14. (2004). Cellular integrins function as entry receptors for human cytomegalovirus via a highly conserved disintegrin-like domain. Proc Natl Acad Sci USA
  15. (1998). Conformational changes in cell surface HIV-1 envelope glycoproteins are triggered by cooperation between cell surface CD4 and co-receptors.
  16. (2009). Coxsackie adenovirus receptor (CAR) regulates integrin function through activation of p44/42 MAPK. Exp Cell Res
  17. (1999). Coxsackievirus and adenovirus receptor cytoplasmic and transmembrane domains are not essential for coxsackievirus and adenovirus infection.
  18. (2001). Curiel DT: CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors. Gene Ther
  19. (2006). Effective highcapacity gutless adenoviral vectors mediate transgene expression in human glioma cells. Mol Ther
  20. entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature
  21. (2009). et al.: CEACAM6 attenuates adenovirus infection by antagonizing viral trafficking in cancer cells.
  22. (1996). et al.: Identification of a major co-receptor for primary isolates of HIV-1. Nature
  23. (2002). Fattaey A: Selectively replicating adenoviruses targeting deregulated E2F activity are potent, systemic antitumor agents.
  24. (1997). Finberg RW: Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science
  25. (1995). FL: Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants. Hum Gene Ther
  26. (1993). Fundamentals of Receptor, Enzyme, and Transport Kinetics. Boca Raton:
  27. (2004). Gene therapy clinical trials worldwide 1989-2004-an overview.
  28. (1998). Greenberg HB: Identification of mutations in the rotavirus protein VP4 that alter sialic-acid-dependent infection.
  29. (2006). HB: Characterization of a panel of cell lines derived from urothelial neoplasms: genetic alterations, growth in vivo and the relationship of adenoviral mediated gene transfer to coxsackie adenovirus receptor expression.
  30. (2002). Heo DS: Reduced expression of coxsackievirus and adenovirus receptor (CAR) in tumor tissue compared to normal epithelium in head and neck squamous cell carcinoma patients. Anticancer Res
  31. (2001). Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5. J Virol
  32. (1999). Hsieh JT: Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy. Cancer Res
  33. (2009). Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1. Blood
  34. (2006). Humphries MJ: Integrin ligands at a glance.
  35. (2001). Influence of adenoviral fiber mutations on viral encapsidation, infectivity and in vivo tropism. Gene Ther
  36. (2000). Integrins alpha2beta1 and alpha4beta1 can mediate SA11 rotavirus attachment and entry into cells.
  37. (1992). Integrins: versatility, modulation, and signaling in cell adhesion. Cell
  38. (2000). JT: The dual impact of coxsackie and adenovirus receptor expression on human prostate cancer gene therapy. Cancer Res
  39. (1995). KM: Synergistic roles for receptor occupancy and aggregation in integrin transmembrane function. Science
  40. (2007). Kuritzkes DR: Chemokine antagonists as therapeutics: focus on HIV-1. Annu Rev Med
  41. (2005). LA: Virus Taxonomy;
  42. (2009). Loss of the coxsackie and adenovirus receptor contributes to gastric cancer progression.
  43. (1998). Mackow ER: beta3 Integrins mediate the cellular entry of hantaviruses that cause respiratory failure.
  44. (2002). McCormick F: Expression of the coxsackie adenovirus receptor in normal prostate and in primary and metastatic prostate carcinoma: potential relevance to gene therapy. Cancer Res
  45. (2002). MJ: Adenovirus fiber disrupts CAR-mediated intercellular adhesion allowing virus escape. Cell
  46. (2006). Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes. Blood
  47. (1996). Nemerow GR: Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells.
  48. (2007). Nemerow GR: Cell integrins: commonly used receptors for diverse viral pathogens. Trends Microbiol
  49. (2001). Nemerow GR: Integrin alpha(v)beta1 is an adenovirus coreceptor.
  50. (1993). Nemerow GR: Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell
  51. (1999). PL: Structure of adenovirus complexed with its internalization receptor, alphavbeta5 integrin.
  52. (2003). PR: CD4-independent infection of HIV and SIV: implications for envelope conformation and cell tropism in vivo. Aids
  53. (1984). RA: The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature
  54. (2001). Raaij MJ: Kinetic analysis of adenovirus fiber binding to its receptor reveals an avidity mechanism for trimeric receptor-ligand interactions.
  55. (2003). Receptor interactions involved in adenoviral-mediated gene delivery after systemic administration in non-human primates. Hum Gene Ther
  56. (2003). Saggio I: Integrin alpha3beta1 is an alternative cellular receptor for adenovirus serotype 5. J Virol
  57. (2005). SP: Loss of coxsackie and adenovirus receptor expression is associated with features of aggressive bladder cancer. Urology
  58. (1999). Stoppelli MP: Urokinase receptor interacts with alpha(v)beta5 vitronectin receptor, promoting urokinasedependent cell migration in breast cancer. Cancer Res
  59. (1996). The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell
  60. (2009). The cell adhesion molecule "CAR" and sialic acid on human erythrocytes influence adenovirus in vivo biodistribution. PLoS Pathog
  61. (1986). The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell
  62. (1968). U: Virus-receptor interaction in an adenovirus system.
  63. (1997). Vitronectin expression in differentiating neuroblastic tumors: integrin alpha v beta 5 mediates vitronectin-dependent adhesion of retinoic-aciddifferentiated neuroblastoma cells.
  64. (1996). Wickham TJ: Comparative analysis of adenovirus fiber-cell interaction: adenovirus type 2 (Ad2) and Ad9 utilize the same cellular fiber receptor but use different binding strategies for attachment.
  65. (2001). Wickham TJ: Reducing the native tropism of adenovirus vectors requires removal of both CAR and integrin interactions.
  66. (2003). WM: Disruption of 3D tissue integrity facilitates adenovirus infection by deregulating the coxsackievirus and adenovirus receptor. Proc Natl Acad Sci USA
  67. (2003). WM: Inhibition of the Raf/MEK/ERK pathway up-regulates expression of the coxsackievirus and adenovirus receptor in cancer cells. Cancer Res
  68. (1998). WSM: Preparation and titration of CsCl-banded adenovirus stock. Methods in Molecular Medicine